Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aurolab Retisil 1500 is a highly purified silicone oil (polydimethylsiloxane) with a viscosity of 1500 cSt, supplied in a pre-filled syringe (PFS). It is designed for use as an intraocular tamponade in complex vitreoretinal surgeries. By providing sustained mechanical pressure, it holds the retina in place against the pigment epithelium, facilitating reattachment and preventing further tearing. The pre-filled syringe format enhances surgical efficiency, maintains sterility, and ensures precise dosing. It is indicated for retinal detachment with giant tears, proliferative vitreoretinopathy (PVR), proliferative diabetic retinopathy (PDR), CMV retinitis, and traumatic retinal detachment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silicone oil.